Lexicon Pharmaceuticals
LXRX
#6299
Rank
โ‚ฌ0.90 B
Marketcap
2,04ย โ‚ฌ
Share price
0.00%
Change (1 day)
125.03%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -โ‚ฌ22.25 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ69.64 Million. In 2025 the company made an earning of -โ‚ฌ43.63 Million, an increase over its 2024 earnings that were of -โ‚ฌ0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ22.25 Million-49.02%
2025 -โ‚ฌ43.63 Million-74.88%
2024 -โ‚ฌ0.18 Billion13.15%
2023 -โ‚ฌ0.16 Billion73.74%
2022 -โ‚ฌ88.35 Million16.16%
2021 -โ‚ฌ76.06 Million49.82%
2020 -โ‚ฌ50.77 Million-147.19%
2019 โ‚ฌ0.10 B-203.42%
2018 -โ‚ฌ0.11 Billion-15.31%
2017 -โ‚ฌ0.13 Billion0.2%
2016 -โ‚ฌ0.13 Billion2920.7%
2015 -โ‚ฌ4.06 Million-95.33%
2014 -โ‚ฌ86.98 Million-3.61%
2013 -โ‚ฌ90.24 Million-5.52%
2012 -โ‚ฌ95.51 Million-4.17%
2011 -โ‚ฌ99.67 Million15.5%
2010 -โ‚ฌ86.3 Million8.36%
2009 -โ‚ฌ79.64 Million-4.81%
2008 -โ‚ฌ83.66 Million28.79%
2007 -โ‚ฌ64.96 Million35.71%
2006 -โ‚ฌ47.87 Million52.91%
2005 -โ‚ฌ31.31 Million-23.89%
2004 -โ‚ฌ41.13 Million-24.19%
2003 -โ‚ฌ54.25 Million-0.48%
2002 -โ‚ฌ54.51 Million44.12%
2001 -โ‚ฌ37.82 Million23.01%
2000 -โ‚ฌ30.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ6.43 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.00 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.46 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.47 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.16 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ68.79 M-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.15 Million-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ12.93 Million-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA